OSR Inc. (OSRH)
2.46
0.99 (67.35%)
At close: Apr 03, 2025, 3:59 PM
2.40
-2.41%
Pre-market: Apr 04, 2025, 07:13 AM EDT
67.35% (1D)
| Bid | 2.36 |
| Market Cap | 47.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -4.31 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.43 |
| Volume | 89,084,023 |
| Avg. Volume (20D) | 2,860,630 |
| Open | 2.07 |
| Previous Close | 1.47 |
| Day's Range | 1.76 - 3.29 |
| 52-Week Range | 1.30 - 13.40 |
| Beta | 1.44 |
About OSRH
OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA....
Industry Biotechnology
Sector Healthcare
IPO Date Mar 21, 2023
Employees 2
Stock Exchange NASDAQ
Ticker Symbol OSRH
18 hours ago
+68.03%
OSR Holdings shares are trading higher after the c...
Unlock content with
Pro Subscription
1 week ago
+136.88%
Osiris Holding shares are trading higher after its subsidiary, Vaximm AG, announced Phase 2a trial results for VXM01 and Avelumab combination therapy in glioblastoma, demonstrating safety and tolerability.